niacinamide has been researched along with Heritable Pulmonary Arterial Hypertension in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is an inhibitor of multi-kinases including tyrosine and serine/threonine kinases." | 1.46 | Sorafenib as a potential strategy for refractory pulmonary arterial hypertension. ( Fukuda, K; Inami, T; Kataoka, M; Kimura, G; Satoh, T; Yoshino, H, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, G | 1 |
| Kataoka, M | 1 |
| Inami, T | 1 |
| Fukuda, K | 1 |
| Yoshino, H | 1 |
| Satoh, T | 1 |
| Weatherald, J | 1 |
| Humbert, M | 2 |
| Guignabert, C | 2 |
| Montani, D | 2 |
| Godinas, L | 1 |
| Seferian, A | 1 |
| Perros, F | 1 |
| Bergot, E | 1 |
| Sibille, Y | 1 |
| Kojonazarov, B | 1 |
| Sydykov, A | 1 |
| Pullamsetti, SS | 1 |
| Luitel, H | 1 |
| Dahal, BK | 1 |
| Kosanovic, D | 1 |
| Tian, X | 1 |
| Majewski, M | 1 |
| Baumann, C | 1 |
| Evans, S | 1 |
| Phillips, P | 1 |
| Fairman, D | 1 |
| Davie, N | 1 |
| Wayman, C | 1 |
| Kilty, I | 1 |
| Weissmann, N | 1 |
| Grimminger, F | 1 |
| Seeger, W | 1 |
| Ghofrani, HA | 1 |
| Schermuly, RT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Untersuchung Des Einflusses PAH-spezifischer Medikation Auf Die rechtsventrikuläre Funktion Bei Patienten Mit Pulmonaler Arterieller Hypertonie (PAH) Unter Basalen Bedingungen[NCT03362047] | Phase 2 | 30 participants (Anticipated) | Interventional | 2018-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for niacinamide and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
Topics: Apoptosis; Benzamides; Cell Proliferation; Dasatinib; Endothelial Cells; ErbB Receptors; Familial Pr | 2013 |
3 other studies available for niacinamide and Heritable Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Sorafenib as a potential strategy for refractory pulmonary arterial hypertension.
Topics: Adolescent; Adult; Arterial Pressure; Dose-Response Relationship, Drug; Familial Primary Pulmonary H | 2017 |
Response to the article "Sorafenib as a potential strategy for refractory pulmonary arterial hypertension".
Topics: Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Niacinamide; Phenylurea Co | 2017 |
Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.
Topics: Animals; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Hypertension, Pu | 2013 |